← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cognitive Pharmaceuticals, Ltd
Toledo, OH
$1,796,059
Total funding
4
Grants
Funding over time
peak $660.5K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$1,796,059 · 4
By mechanism
R44$1,196,328 · 2
R43$599,731 · 2
Investigators at Cognitive Pharmaceuticals, Ltd
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a Selective Muscarinic Agonist for the Treatment of Schizophrenia$446,844
R44 · FY2007 · MH
Utility of Muscarinic Agonists for Alzheimer's disease$410,796
R44 · FY2005 · AG
Utility of Muscarinic Agonists for Alzheimer's disease$338,688
R44 · FY2004 · AG
Utility of Muscarinic Agonists in Schizopherenia$250,000
R43 · FY2004 · MH
Utility of Muscarinic Agonists in Schizopherenia$249,731
R43 · FY2005 · MH
Utility of Muscarinic Agonists for Alzheimer's disease$100,000
R43 · FY2002 · AG